Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice Anymore
Top Cited Papers
Open Access
- 1 January 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 44 (1), 79-86
- https://doi.org/10.1086/510079
Abstract
Since the advent of the modern era of antimicrobial chemotherapy in the 1930s, animal infection models have allowed for the in vivo evaluation of antimicrobial agents for the treatment of experimentally induced infection. Today, animal pharmacokinetic-pharmacodynamic (PK-PD) infection models serve as a cornerstone of the preclinical assessment process for antibacterial agents and dose and dosing interval selection, as decision support for setting in vitro susceptibility breakpoints, and, finally, for the evaluation of the meaning of in vitro resistance. Over the past 15 years, considerable PK-PD data have been derived from infected patients for many classes of antimicrobial agents. These data provide the opportunity to confirm knowledge gained from animal PK-PD infection models.Keywords
This publication has 25 references indexed in Scilit:
- Application of an In Vitro Infection Model and Simulation for Reevaluation of Fluoroquinolone Breakpoints for Salmonella enterica Serotype TyphiAntimicrobial Agents and Chemotherapy, 2005
- Relationship between Fluoroquinolone Area under the Curve:Minimum Inhibitory Concentration Ratio and the Probability of Eradication of the Infecting Pathogen, in Patients with Nosocomial PneumoniaThe Journal of Infectious Diseases, 2004
- Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapyJCI Insight, 2003
- Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime timeCurrent Opinion in Microbiology, 2000
- Pharmacodynamics of LevofloxacinJAMA, 1998
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998
- Pharmacodynamics of intravenous ciprofloxacin in seriously ill patientsAntimicrobial Agents and Chemotherapy, 1993
- Postantibiotic effect of imipenem on Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1984
- Continuous vs. Discontinuous Therapy with PenicillinThe New England Journal of Medicine, 1953
- Effect of schedule of administration on the therapeutic efficacy of penicillin: Importance of the aggregate time penicillin remains at effectively bactericidal levelsAmerican Journal Of Medicine, 1950